WELIXE contains Tranexamic Acid 100 mg/5 mL Injection, an antifibrinolytic formulation for control and reduction of excessive bleeding in appropriate clinical situations. A key PCD Pharma Gynae & Haemostatic Injectable product.
Control of excessive bleeding in selected clinical situations.
No, it helps prevent breakdown of established clots.
Use strictly as prescribed. Inform the physician about a history of thrombosis, kidney disease or visual problems. Seek urgent help for chest pain, breathlessness or limb swelling.
Nausea, headache, dizziness, abdominal discomfort and fatigue may occur. Thrombotic events are uncommon but clinically important.
WELIXE: Tranexamic Acid inhibits fibrinolysis and helps stabilize formed fibrin clots, thereby reducing excessive bleeding.
